Page 2 - Translational Informatics Division News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Translational informatics division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Translational Informatics Division Today - Breaking & Trending Today

Insilico Medicine discovers novel preclinical candidate to address idiopathic pulmonary fibrosis


Insilico Medicine discovers novel preclinical candidate to address idiopathic pulmonary fibrosis
Insilico Medicine has demonstrated a breakthrough in Artificial Intelligence ( AI ) and drug discovery linking together generative chemistry and biology for the first time to discover a novel preclinical candidate addressing idiopathic pulmonary fibrosis ( IPF ) and be validated with multiple human cell and animal model experiments.
Often found implicated in a wide range of diseases and multiple organs such as lung, liver and kidney, IPF addresses a very broad medical need that affects hundreds of thousands of individuals worldwide.
The pinnacle of the deep learning revolution can be pinged to 2014 when deep learning systems accelerated by NVIDIA GPUs and AI software started outperforming humans in image recognition and generative adversarial networks were invented. It is also the year when we started the company. In 2016 we demonstrated that a deep learning system can ....

Feng Ren , Alex Zhavoronkov , Charles Cantor , Emily Henderson , Jensen Huang , Tudor Oprea , University Of Toronto , Translational Informatics Division , University Of New Mexico , Founder Of Retrotope Inc , Professor Emeritus At Boston University , Founder Of Sequenom Inc , Artificial Intelligence , Chief Science , Insilico Medicine , Structure Based Drug Design , Ligand Based Drug Design , New Mexico , Professor Emeritus , Boston University , Science Advisory Board , Sequenom Inc , Computer Science , Animal Model , Clinical Trial , Deep Learning ,

Insilico Medicine Achieves Industry First Nominating Preclinical Candidate Discovered by AI


Insilico Medicine Achieves Industry First Nominating Preclinical Candidate Discovered by AI
Insilico Medicine Achieves Industry First Nominating Preclinical Candidate for Idiopathic Pulmonary Fibrosis With Both Novel Drug Target and Novel Molecule Discovered by Artificial Intelligence
HONG KONG, Feb. 24, 2021 /PRNewswire/ Insilico Medicine has demonstrated a breakthrough in Artificial Intelligence ( AI ) and drug discovery - linking together generative chemistry and biology for the first time - to discover a novel preclinical candidate addressing idiopathic pulmonary fibrosis
( IPF ) and be validated with multiple human cell and animal model experiments. Often found implicated in a wide range of diseases and multiple organs such as lung, liver and kidney, IPF addresses a very broad medical need that affects hundreds of thousands of individuals worldwide. ....

Feng Ren , Kostenloser Wertpapierhandel , Alex Zhavoronkov , Charles Cantor , Jensen Huang , Tudor Oprea , University Of Toronto , Translational Informatics Division , University Of New Mexico , Founder Of Retrotope Inc , Professor Emeritus At Boston University , Founder Of Sequenom Inc , Novel Molecule Discovered , Artificial Intelligence , Insilico Medicine , Chief Science , Structure Based Drug Design , Ligand Based Drug Design , Additional Information , New Mexico , Professor Emeritus , Boston University , Science Advisory Board , Sequenom Inc , Computer Science , ஃபெங் ரென் ,